Spec-first · Factory-neutralCertificates checked at source

Product Guides

Alginate vs Hydrofiber Dressings: A Specification Comparison

Compare alginate and plain AQUACEL EXTRA dressing quotes by material, format, reference, pack quantity and IFU, with US examples and unresolved fields.

· · 10 min read

Illustrative still life of unbranded white fibrous dressing pads in several sizes and a coiled rope-shaped dressing, with a stainless-steel tray edge and a green leaf on off-white linen.

For an alginate versus Hydrofiber purchasing comparison, begin with the exact product and material. KALTOSTAT is calcium-sodium alginate; plain AQUACEL EXTRA is a sodium carboxymethylcellulose (NaCMC) pad with strengthening fiber. Compare the reference, pad or rope format, stated size or mass, box quantity, market and instructions for use (IFU) before changing the item master. Both retrieved IFUs describe sterile, single-use primary dressings with a secondary cover. These fields establish what is being offered; clinical suitability still needs the responsible professional’s assessment. See the KALTOSTAT IFU and plain AQUACEL EXTRA IFU.

The examples below are a bounded sample from two Convatec product families, checked on 17 November 2026. They are US ordering examples supported by manufacturer documents, with a separate New Zealand source used only to explain original AQUACEL terminology. They do not establish market-wide rankings, independent test results or clinical interchangeability.

Start with the material and exact variant

An item described only as “alginate” or “Hydrofiber” leaves purchasing fields unresolved. Record the complete named variant before comparing quotations. In this article, the Hydrofiber ordering rows refer specifically to plain AQUACEL EXTRA with strengthening fiber. An offer for another AQUACEL variant needs its own product record and supporting document.

The New Zealand original AQUACEL page describes that original dressing as derived from 100% sodium carboxymethylcellulose. Keep this statement attached to that product and market. The separately retrieved EXTRA IFU identifies NaCMC with strengthening fiber but does not disclose the reinforcing fiber’s chemistry or fraction. Do not copy the original product’s percentage into the EXTRA composition field.

For KALTOSTAT, the manufacturer’s product description identifies a nonwoven calcium-sodium alginate pad or ribbon. The calcium-to-sodium proportions are not established by the documents used here. A purchasing specification can preserve the disclosed material name while leaving an undisclosed proportion unknown; a plausible formulation is not a verified specification.

Compare four named US ordering references

The ordering table separates physical format from order quantity. Sizes and counts come from the US catalogs; document linkage is described immediately below. The rope’s 2 g entry is a mass, whereas the pad entries give two dimensions. None of these fields measures comparative absorbency.

US-market product and formatReferenceDisclosed constructionStated size or massDressings per boxOrdering source
KALTOSTAT Calcium Sodium Alginate Dressing — rectangle168214Calcium-sodium alginate fiber10 × 20 cm10US KALTOSTAT catalog
KALTOSTAT Calcium Sodium Alginate Dressing — rope168117Calcium-sodium alginate fiber2 g5US KALTOSTAT catalog
AQUACEL EXTRA Hydrofiber Dressing with Strengthening Fiber — pad420671NaCMC with strengthening fiber5 × 5 cm10US EXTRA catalog; reference index
AQUACEL EXTRA Hydrofiber Dressing with Strengthening Fiber — pad420673NaCMC with strengthening fiber15 × 15 cm5US EXTRA catalog; reference index

Attach the label evidence and missing fields

References coveredRetrieved IFU and revisionSterility and use designationSecondary cover fieldStill to confirm
168214; 1681171117441V2; revised 2025-09Sterile; single use; pouch-integrity conditions applySpecified in the product descriptionInsert supplied with quoted US stock; material proportions; rope length and diameter
420671; 4206731704695V1; revised 2025-06; NAI RX index linkageSterile; single use; package-integrity conditions applySpecified in the product descriptionLocal supplied label and IFU; strengthening-fiber chemistry and fraction

For EXTRA, the NAI RX index explicitly maps both listed references to document 1704695V1. For KALTOSTAT, the ordering page establishes the reference and pack fields, while 1117441V2 supplies the family description. Confirm the insert actually supplied with either quoted KALTOSTAT reference. A family-level document is useful evidence, but the quotation still needs a local label match.

Read pad, rope and box fields separately

Keep dimensions and mass in separate fields. A 10 × 20 cm rectangle and a 2 g rope cannot be aligned by treating both entries as “size.” The cited KALTOSTAT catalog does not state the rope’s length or diameter. Leave those fields unknown rather than estimating them from a photograph, another supplier’s rope or the mass alone.

Also distinguish an individual dressing, a box and any outer shipping case. The ordering sources give dressings per box; an outer-case quantity requires separate supplier confirmation. An ambiguous “quantity 10” on a quotation is insufficient if the purchase-order unit could mean either ten dressings or ten boxes.

Consider a hypothetical quotation entered as “one box” for 168214 and another as “one box” for 168117. The cited ordering quantities mean ten rectangles in the first box and five ropes in the second. Record those pack relationships before comparing prices. This example illustrates order-unit reconciliation; it supplies no price, cost-saving estimate or clinically equivalent quantity.

For a tender or item-master change, retain the manufacturer reference and distributor code in separate fields, then ask the distributor to identify the mapping. A distributor’s short description can be a useful search aid, but the proposed change should be reviewable against the complete manufacturer product name and reference.

Keep the product name, market and IFU together

Document control needs more than an undated IFU link. Save the identifier, revision shown inside the document, source market, retrieval date and the supplier’s confirmation of which insert accompanies the offer. This creates a record another reviewer can check without relying on the original buyer’s memory.

The retrieved KALTOSTAT footer shows 1117441V2, revised 2025-09. The EXTRA footer shows 1704695V1, revised 2025-06. Its NAI RX index displays a website publication date of 21 November 2025. These are different kinds of dates. An index publication date does not replace the revision printed inside an IFU, and neither date confirms current distributor stock.

Both IFUs contain product-specific qualifications beyond the short material descriptions. Keep those qualifications available to the clinical reviewer rather than turning the category name into a treatment rule. This specification comparison does not prescribe application, removal, packing or a dressing-change schedule.

Regulatory identification is a separate review field. The site’s wound-dressing classification guide addresses that question. Use the present comparison to document the named material and ordering configuration, and obtain the appropriate regulatory evidence for the proposed SKU through the responsible review process.

Resolve the conflicting dimensions for reference 420674

One additional EXTRA reference illustrates why identical order codes still need source reconciliation. On 17 November 2026, the two manufacturer pages showed the following values:

SourceReferenceDisplayed dimension
US product catalog42067410 × 12.5 cm
NAI RX IFU index42067410 × 12 cm

Keep 420674 outside the completed comparison rows until the intended supply record is resolved. Retain both observations and ask for the current pack label or written manufacturer clarification identifying the reference, market and correct dimension. Record who supplied the clarification and when. The evidence does not establish whether the difference reflects a catalog error, a market distinction or another cause.

A practical purchasing hold can be narrow: leave this reference’s dimension unconfirmed while continuing to assess the other documented rows. Do not silently select one value, average the dimensions or treat a nominal size as a verified usable area. Once clarified, update the affected record and preserve the explanation for the change.

Ask for evidence behind performance claims

The KALTOSTAT manufacturer description reports a firm gel/fiber response to fluid; the EXTRA description reports a soft gel. Those descriptions do not provide a common numerical scale for ranking the products. No matched laboratory or clinical outcome dataset was assembled for this comparison. Absorbency multiples, healing superiority, infection outcomes and universal wear periods therefore remain outside its conclusions.

If a bidder adds a numerical claim, request a report that lets the reviewer understand what was actually compared. The following is a proposed buyer checklist, not a claim that either product has passed a particular test:

  • Product identity: name the exact tested reference and variant, including whether the comparator was the same plain product offered in the quotation.

  • Method: identify the test procedure and version, report date and laboratory. A promotional graph without that information leaves the basis uncertain.

  • Conditions: state the test fluid, conditioning, duration and any load or pressure used. Ask which conditions differed between the offered results.

  • Result definition: retain the units and calculation basis, including whether the value describes a whole specimen, area or mass. Do not compare unlike denominators.

  • Comparator and limits: identify the comparator’s size and construction, the number of specimens and the reported variability or limitations.

Record an absent report as “unknown,” with a named owner for follow-up. A material disclosure is one evidence field; a measured performance result is another. Clinical outcome evidence needs its own assessment. Keeping these records distinct allows a purchasing team to compare a documented offer without promising an outcome the supplied evidence cannot establish.

Record the proposed supply change

The useful output is a reviewable purchasing record. Build it around the exact quote rather than a generic category label. A compact record can contain:

  • Identity and market: complete product name, plain or other variant, manufacturer reference, distributor code and destination market.

  • Physical and order fields: pad or rope, labeled dimensions or mass, dressing count per box, purchase-order unit and any separately confirmed outer-case quantity.

  • Label evidence: current pack label, supplied IFU identifier and revision, sterile/single-use designation, secondary-cover requirement and retrieval date.

  • Open decisions: missing composition fields, unresolved source conflicts, requested performance reports, responsible reviewer and the decision for each issue.

Keep the quotation and the evidence record linked through the review. If a supplier revises the reference, pack count or source document before delivery, return the changed fields to the appropriate owner. Do not overwrite a previously checked value without retaining the basis for the revision.

Storage and supplier responsibilities also belong in the purchasing review. For supporting checks, use the guides to labeled storage and transport and supplier quality agreements. Their role is to support those separate records; they do not establish equivalence between the dressings in this table.

Before changing the item master, the buyer should be able to show which fields are verified, which remain open and who assessed the proposed change. For this comparison, the verified contribution is the named material, format, ordering-reference and document record. The final clinical selection remains with the responsible professional using the current local labeling.

Sources

Manufacturer pages and IFUs checked on 17 November 2026. Ordering fields are source-dated and require confirmation against the quoted stock. Product facts below rely on manufacturer disclosures; the internal classification article provides navigation to a separate review topic.